Sawai Pharmaceutical | Sustainability Performance
Manufacturer of generic pharmaceutical products.
1929
Japan
1,001 - 5,000 employees
Pharmaceuticals
$1B - 10B in revenue
$25M - 100M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#8784
Overallⓘ#432
in Japanⓘ#212
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
- Sawai Group Holdings Co Ltd (formerly Sawai Pharmaceutical), Japanese major generics, has faced sustained Japanese MHLW (Ministry of Health, Labour and Welfare) enforcement scrutiny over the contested 2024 USD 1+ billion Sawai Sumika Pharmaceutical generic pharmaceutical contamination scandal affecting Japanese institutional shareholders amid the broader Japanese generic pharma market normalization pressure.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
1
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.